Artemisinin pretreatment mitigates MI/R-induced myocardial inflammation, cardiomyocyte apoptosis, and myocardial fibrosis primarily by inhibiting the NLRP3 inflammasome (160). Here, NLRP3 is linked to Myocardial fibrosis.